Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery
Phase 4
Terminated
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Placebo (placebo comparator)Drug: Nux vomica (active comparator)
- Registration Number
- NCT00861237
- Lead Sponsor
- Medical University of Vienna
- Brief Summary
After heart surgery, about 30% of patients suffer from atrial fibrillation. Patients are randomized into two groups receiving either potentized Strychnos Nux vomica or placebo under double blind conditions. Postoperatively, ECGs are done to monitor cardiac rhythm.
- Detailed Description
Preoperatively, patients receive potentized Nux vomica or placebo sublingually. Then, patients are observed regarding atrial fibrillation postsurgical. The difference between the group of patients with and without nux vomica is recorded.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine.
Exclusion Criteria
- Pregnant patients
- Patients with preoperative atrial fibrillation and/or hyperthyreosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo globules group Placebo (placebo comparator) Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery. Nux vomica group Nux vomica (active comparator) Patients receive Nux vomica globules made out of sugar sublingually before surgery.
- Primary Outcome Measures
Name Time Method Frequency of atrial fibrillation after heart surgery with heart lung machine 24 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Dept Surgery, Med Univ Vienna
🇦🇹Vienna, Austria